| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |